摘要
骨髓间充质干细胞是多潜能祖细胞,能够分化为成骨细胞、软骨细胞、脂肪细胞。为阐明潜在的机制及广泛的临床应用,在体内外的实验研究里,这些细胞被刺激表现出显著的免疫调节性能。本篇我们描述了骨髓间充质干细胞对免疫细胞的影响及其在动物模型和自身免疫性疾病的临床试验中的应用。应该指出的是,虽然临床应用的数量正在稳步增加,为避免过高的错误的期望,应谨慎解释其结果。主要在临床应用的争议是骨髓间充质干细胞的异质性及其治疗后随访的不可预知的行为。然而,越来越多的对外源性细胞和宿主组织之间的相互作用的认识以及部分令人鼓舞的临床观察表明,在不久的将来我们在坚实的基础上将进一步扩展骨髓间充质干细胞的治疗应用。
关键词: 动物模型,自身免疫性疾病,临床试验,骨髓间充质干细胞/基质细胞
图形摘要
Current Drug Targets
Title:The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease
Volume: 17 Issue: 2
Author(s): Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca
Affiliation:
关键词: 动物模型,自身免疫性疾病,临床试验,骨髓间充质干细胞/基质细胞
摘要: Mesenchymal stem cells are multipotent progenitors able to differentiate into osteoblasts, chondrocytes and adipocytes. These cells also exhibit remarkable immune regulatory properties, which stimulated both in vitro and in vivo experimental studies to unravel the underlying mechanisms as well as extensive clinical applications. Here, we describe the effects of MSCs on immune cells and their application in animal models as well as in clinical trials of autoimmune diseases. It should be pointed out that, while the number of clinical applications is increasing steadily, results should be interpreted with caution, in order to avoid rising false expectations. Major issues conditioning clinical application are the heterogeneity of MSCs and their unpredictable behavior following therapeutic administration. However, increasing knowledge on the interaction between exogenous cell and host tissue, as well as some encouraging clinical observations suggest that the therapeutic applications of MSCs will be further expanded on firmer grounds in the near future.
Export Options
About this article
Cite this article as:
Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca , The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease, Current Drug Targets 2016; 17 (2) . https://dx.doi.org/10.2174/1389450116666150722140633
DOI https://dx.doi.org/10.2174/1389450116666150722140633 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Current Gene Therapy KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Role of Inflammation in the Development of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets CD24 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Targeting Redundancy for Immunotherapy?
Current Immunology Reviews (Discontinued) Biologics in Inflammatory Immune-mediated Systemic Diseases
Current Pharmaceutical Biotechnology Candidate Genes Implicated in Type 1 Diabetes Susceptibility
Current Diabetes Reviews The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis
Current Pharmaceutical Design T Cell-Activated Signaling Pathways and Locally Produced Cytokines as Potential Targets in Celiac Disease
Current Drug Targets B-Cell Based Gene Therapy for Inducing Tolerance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Characteristics of Autoimmune Pancreatitis
Current Pharmaceutical Design A Quantitative Structure-Activity Relationship Study on Some Series of Potassium Channel Blockers
Medicinal Chemistry miRNA Functions in Arthritis
Current Rheumatology Reviews siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases
Reviews on Recent Clinical Trials NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer
Current Medicinal Chemistry Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus
Current Pharmaceutical Design Obstructive Sleep Apnea and Autoimmune Rheumatic Disease: Is there Any Link?
Inflammation & Allergy - Drug Targets (Discontinued) Autoimmunity and Apoptosis - Therapeutic Implications
Current Medicinal Chemistry